Treatment and Management of Chronic Inflammatory Bowel Diseases: Optimizing Present and Future Therapeutic Choices

J Clin Med. 2022 Sep 6;11(18):5267. doi: 10.3390/jcm11185267.

Abstract

Inflammatory bowel diseases (IBD) are chronic relapsing diseases of the gastrointestinal tract of unknown origin, resulting from an aberrant immune response to microbial and gut-specific antigens in genetically susceptible patients [...].

Publication types

  • Editorial

Grants and funding

This research received no external funding.